China Life Insurance Company Limited (2628) forecasts its net profit for the first three quarters of 2025 under ASBE to reach approximately RMB156,785 million to RMB177,689 million, representing a 50% to 70% increase compared to the same period in 2024. In 2024, the corresponding net profit stood at RMB104,523 million.
The announcement highlights China Life’s focus on value creation, profitability enhancement, and continuous asset-liability interaction. The company also cites its efforts in diversifying product and business portfolios, combined with cross-cycle investment deployment to leverage the recovery of the stock market, as key drivers behind the projected profit increase.
China Life states that its detailed financial results for the first three quarters of 2025 will be disclosed in the upcoming third quarter report for that year.